Avient (AVNT) Draws Income Interest, Is The Valuation Upside Still There?

Recent attention on Avient (AVNT) has centered on its dividend profile and earnings outlook, after research highlighted a higher yield, a multiyear pattern of dividend increases, and relatively attractive valuation metrics versus peers.

The recent pullback, with a 7 day share price return down 3.88% and a 30 day share price return down 8.21% to US$41.90, comes after a stronger run that left Avient with a 90 day share price return of 14.73% and a year to date share price return of 32.14%. The 1 year total shareholder return of 18.53% and 3 year total shareholder return of 22.98% suggest momentum has cooled but not reversed as investors weigh the richer dividend profile and earnings outlook against valuation.

Scan beyond Avient and compare its dividend and valuation profile with a curated set of peers through the 49 high quality undervalued stocks that investors are watching closely.

The pullback now sets up a simple tension for Avient investors. Are you seeing early cracks in the business, or just sentiment cooling around a still solid earnings and dividend story that valuation has yet to fully reflect?

Most Popular Narrative: 8.9% Undervalued

Against Avient's last close at $41.90, the most followed narrative anchors on a fair value of $46.00 and frames that gap through earnings quality and mix.

Although growth vectors such as health care, defense and materials tied to artificial intelligence and data center buildout are gaining traction, they currently offset weakness in roughly 80% of the portfolio rather than driving broad-based expansion. This may keep overall revenue and EBITDA growth modest.

Read the complete narrative.

Investors may want to see what kind of revenue path and margin profile support that $46.00 figure. The narrative leans on specific growth rates, profitability shifts, and a tighter discount rate to get there.

Result: Fair Value of $46.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, if Avient’s higher growth niches like health care and defense scale faster than expected, or if productivity gains outpace cost pressures, this could support a stronger case for upside.

Find out about the key risks to this Avient narrative.

Next Steps

Mixed signals around Avient's income potential and valuation mean opinion will split. Move quickly, review the data, and weigh the 5 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Avient?

Do not stop with Avient. Use the Simply Wall Street Screener to surface fresh opportunities that fit the kind of portfolio you actually want to build.

• Target reliable cash generators by scanning a focused set of income candidates through the 6 dividend fortresses.
• Hunt for quality at a reasonable entry point by working through the carefully filtered 49 high quality undervalued stocks.
• Protect your capital first by shortlisting resilient candidates using the 80 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com